CRISTEN DEGRAFFENREID: Open Payments
NPI 1093497885 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,285 in 176 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $409 · 2025 $3,285
Food & beverage: $3,285
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 27 | $562 |
| Noven Therapeutics, LLC | 25 | $420 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $359 |
| Otsuka America Pharmaceutical, Inc. | 18 | $328 |
| Alkermes, Inc. | 15 | $273 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $266 |
| ABBVIE INC. | 23 | $253 |
| Vanda Pharmaceuticals Inc. | 12 | $238 |
| Bausch Health US, LLC | 6 | $142 |
| Neurocrine BioSciences, Inc. | 7 | $121 |
Products named: Xelstrym, Auvelity, CAPLYTA, REXULTI, TRINTELLIX, VRAYLAR, FANAPT, Sunosi.
Industry payments across OK — which companies pay providers there.
